SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A narrative synthesis of research with 5-MeO-DMT
16 references·2 citing·34 second hop
A narrative synthesis of research with 5-MeO-DMT (2021)A narrative synthesis of research with 5-…Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Psilocybin with psychological…Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Rapid and sustained symptom r…Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psilocybin with psychological…Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin produces substanti…Examining the factor structure of the 39-item and 15-item versions of the Five Facet Mindfulness Questionnaire before and after mindfulness-based cognitive therapy for people with recurrent depression. (2016)Examining the factor structur…Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin (2015)Validation of the revised Mys…Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015)Psilocybin-assisted treatment…Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction (2014)Pilot study of the 5-HT 2A R …Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Pilot Study of Psilocybin Tre…Human hallucinogen research: guidelines for safety (2008)Human hallucinogen research: …Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Hallucinogens Recruit Specifi…The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): Construct validity and normative data in a large non‐clinical sample (2005)The short‐form version of the…Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study (2004)Acute psychological and physi…Brief Symptom Inventory-18 (2000)Brief Symptom Inventory-18Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers (1992)Plants of the Gods: Their Sac…[Biological psychiatry]. (1980)[Biological psychiatry].Structural pharmacology and therapeutic potential of 5-methoxytryptamines (2024)Structural pharmacology and t…Drug–drug interactions involving classic psychedelics: A systematic review (2023)Drug–drug interactions involv…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Hallucinogens (2004)The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo (2021)The Hospital Anxiety and Depression Scale (1983)Development and validation of brief measures of positive and negative affect: The PANAS scales. (1988)Development and validation of brief measures of positive and negative affect: The PANAS scales. (1988)The Depression Anxiety Stress Scales—21 (DASS‐21): Further Examination of Dimensions, Scale Reliability, and Correlates (2012)Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese (2013)Development and Validation of a Brief Version of the Difficulties in Emotion Regulation Scale: The DERS-16 (2015)The varieties of religious experience: A study in human nature. (1902)Universals in the Content and Structure of Values: Theoretical Advances and Empirical Tests in 20 Countries (1992)Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. (2002)Neural correlates of the LSD experience revealed by multimodal neuroimaging (2016)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)DSM‐IV‐TR: Diagnostic and Statistical Manual of Mental Disorders (2013)An Inventory for Measuring Depression (1961)The Brief Psychiatric Rating Scale (1962)Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Diagnostic and Statistical Manual of Mental Disorders (2013)Psychedelics Promote Structural and Functional Neural Plasticity (2018)Manual for the State-Trait Anxiety Inventory (1970)Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. (1985)Psychedelics (2016)Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Trial of Psilocybin versus Escitalopram for Depression (2021)The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018)An automated version of the digit symbol substitution test (DSST) (1982)The Effect of Psychosocial Stress on Sleep: A Review of Polysomnographic Evidence (2007)Evidence-based Kernels: Fundamental Units of Behavioral Influence (2008)
this work references cited by second hop

References

  • 2005The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): Construct validity and normative data in a large non‐clinical sample5,796 cited
  • 2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
  • 2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited
  • 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
  • 2010Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer1,205 cited
  • 2008Human hallucinogen research: guidelines for safety1,201 cited
  • 2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
  • 1980[Biological psychiatry].1,081 cited
  • 2017Psilocybin with psychological support for treatment-resistant depression: six-month follow-up969 cited
  • 2007Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior922 cited
  • 2014Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction913 cited
  • 2000Brief Symptom Inventory-18655 cited
  • 2015Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

635 cited
  • 1992Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers466 cited
  • 2004Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study451 cited
  • 2016Examining the factor structure of the 39-item and 15-item versions of the Five Facet Mindfulness Questionnaire before and after mindfulness-based cognitive therapy for people with recurrent depression.430 cited
  • Cited by

    • 2024Structural pharmacology and therapeutic potential of 5-methoxytryptamines79 cited
    • 2023Drug–drug interactions involving classic psychedelics: A systematic review69 cited